Filings
Finds words inside filing documents. Searching ArriVent BioPharma, Inc.'s filings · 43 documents indexed.
2 documents · 14 matches
-
AVBP ArriVent BioPharma, Inc. DRS/A 2023-10-04
material weakness we identified or develop or to maintain internal control over financial reporting could severely inhibit our ability to accurately11 matches in this document -
AVBP ArriVent BioPharma, Inc. 10-K 2026-03-05
Item 1A. Risk Factors
material weakness or uncover other errors in financial reporting. During the course of our evaluation of these material weaknesses, we may identify3 matches in this document
Page 1 of 1 · 2 documents